{"id":"https://openalex.org/W2015994420","doi":"https://doi.org/10.1111/j.1365-2133.1988.tb01772.x","title":"Low-dose cyclosporin A in severe psoriasis. A double-blind study","display_name":"Low-dose cyclosporin A in severe psoriasis. A double-blind study","publication_year":1988,"publication_date":"1988-02-01","ids":{"openalex":"https://openalex.org/W2015994420","doi":"https://doi.org/10.1111/j.1365-2133.1988.tb01772.x","mag":"2015994420","pmid":"https://pubmed.ncbi.nlm.nih.gov/3280000"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2133.1988.tb01772.x","doi":"https://doi.org/10.1111/j.1365-2133.1988.tb01772.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2133.1988.tb01772.x","pdf_url":null,"source":{"id":"https://openalex.org/S45720283","display_name":"British Journal of Dermatology","issn_l":"0007-0963","issn":["0007-0963","1365-2133"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Dermatology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109089904","display_name":"Th. van Joost","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]},{"id":"https://openalex.org/I4405267036","display_name":"Academisch Ziekenhuis Rotterdam","ror":"https://ror.org/00xtwy257","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4405267036"]},{"id":"https://openalex.org/I913958620","display_name":"Erasmus University Rotterdam","ror":"https://ror.org/057w15z03","country_code":"NL","type":"education","lineage":["https://openalex.org/I913958620"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"TH. JOOST","raw_affiliation_strings":["Department of Dermato-Venereology, University Hospital Rotterdam Dijkzigt, Erasmus University, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermato-Venereology, University Hospital Rotterdam Dijkzigt, Erasmus University, The Netherlands","institution_ids":["https://openalex.org/I2801952686","https://openalex.org/I4405267036","https://openalex.org/I913958620"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108385554","display_name":"Jan Dositheus Bos","orcid":"https://orcid.org/0009-0003-6744-3244","observed_orcids":["https://orcid.org/0009-0003-6744-3244"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"J.D. BOS","raw_affiliation_strings":["Department of Dermato\u2010Venereology, Academisch Medisch Centrum, University of Amsterdam, The Netherlands","Other departments"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermato\u2010Venereology, Academisch Medisch Centrum, University of Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I887064364"]},{"raw_affiliation_string":"Other departments","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064861085","display_name":"Freerk Heule","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]},{"id":"https://openalex.org/I4405267036","display_name":"Academisch Ziekenhuis Rotterdam","ror":"https://ror.org/00xtwy257","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4405267036"]},{"id":"https://openalex.org/I913958620","display_name":"Erasmus University Rotterdam","ror":"https://ror.org/057w15z03","country_code":"NL","type":"education","lineage":["https://openalex.org/I913958620"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"F. HEULE","raw_affiliation_strings":["Department of Dermato\u2010Venereology, University Hospital Rotterdam Dijkzigt, Erasmus University, Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermato\u2010Venereology, University Hospital Rotterdam Dijkzigt, Erasmus University, Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I2801952686","https://openalex.org/I4405267036","https://openalex.org/I913958620"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109232875","display_name":"Marcus M. H. M. Meinardi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"M.M.H.M. MEINARDI","raw_affiliation_strings":["Department of Dermato\u2010Venereology, Academisch Medisch Centrum, University of Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermato\u2010Venereology, Academisch Medisch Centrum, University of Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I887064364"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3731,"currency":"GBP","value_usd":4920},"apc_paid":null,"fwci":10.3684,"has_fulltext":false,"cited_by_count":181,"citation_normalized_percentile":{"value":0.98789911,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"118","issue":"2","first_page":"183","last_page":"190"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyclosporine","display_name":"cyclosporine","score":0.9950000047683716},{"id":"https://openalex.org/keywords/plaque-psoriasis","display_name":"plaque psoriasis","score":0.8289999961853027},{"id":"https://openalex.org/keywords/severe-psoriasis","display_name":"severe psoriasis","score":0.7689999938011169},{"id":"https://openalex.org/keywords/low-dose-immunosuppressive-therapy","display_name":"low-dose immunosuppressive therapy","score":0.8159999847412109},{"id":"https://openalex.org/keywords/psoriasis-area-and-severity-index","display_name":"Psoriasis Area and Severity Index","score":0.871999979019165},{"id":"https://openalex.org/keywords/remission-maintenance","display_name":"remission maintenance","score":0.7820000052452087},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.8880000114440918},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.906000018119812},{"id":"https://openalex.org/keywords/nephrotoxicity","display_name":"nephrotoxicity","score":0.7720000147819519},{"id":"https://openalex.org/keywords/serum-creatinine","display_name":"serum creatinine","score":0.6579999923706055},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.5910000205039978}],"concepts":[{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.8758856058120728},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8439500331878662},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7446425557136536},{"id":"https://openalex.org/C2777011040","wikidata":"https://www.wikidata.org/wiki/Q390643","display_name":"Psoriasis Area and Severity Index","level":3,"score":0.6948634386062622},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5336808562278748},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5208142995834351},{"id":"https://openalex.org/C2780306776","wikidata":"https://www.wikidata.org/wiki/Q426660","display_name":"Creatinine","level":2,"score":0.47949129343032837},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4343078136444092},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4328257441520691},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.41199082136154175},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.1724015772342682},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003524","descriptor_name":"Cyclosporins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D003524","descriptor_name":"Cyclosporins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003524","descriptor_name":"Cyclosporins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011897","descriptor_name":"Random Allocation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1111/j.1365-2133.1988.tb01772.x","doi":"https://doi.org/10.1111/j.1365-2133.1988.tb01772.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2133.1988.tb01772.x","pdf_url":null,"source":{"id":"https://openalex.org/S45720283","display_name":"British Journal of Dermatology","issn_l":"0007-0963","issn":["0007-0963","1365-2133"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Dermatology","raw_type":"journal-article"},{"id":"pmid:3280000","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3280000","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The British journal of dermatology","raw_type":"Clinical Trial"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/35c860fa-ba26-4ebb-90ff-52a51aae3333","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/lowdose-cyclosporin-a-in-severe-psoriasis-a-doubleblind-study(35c860fa-ba26-4ebb-90ff-52a51aae3333).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"British journal of dermatology, 118(2), 183 - 190. Wiley-Blackwell","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/92aa98a0-f679-4616-b559-a94672ab9c8f","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/92aa98a0-f679-4616-b559-a94672ab9c8f","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"van Joost, T, Bos, J D, Heule, F & Meinardi, M M 1988, 'Low-dose cyclosporin A in severe psoriasis. A double-blind study', British journal of dermatology, vol. 118, no. 2, pp. 183-190.","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1964442012","https://openalex.org/W2001207556","https://openalex.org/W2016293272","https://openalex.org/W2016370774","https://openalex.org/W2030766095","https://openalex.org/W2038676752","https://openalex.org/W2041679790","https://openalex.org/W2052606181","https://openalex.org/W2059686909","https://openalex.org/W2064697251","https://openalex.org/W2066723587","https://openalex.org/W2067327580","https://openalex.org/W2087689949","https://openalex.org/W2115710949","https://openalex.org/W2142262544","https://openalex.org/W2156749810","https://openalex.org/W2321199594","https://openalex.org/W2401279855","https://openalex.org/W2409421526","https://openalex.org/W2885719909","https://openalex.org/W4231163362"],"related_works":["https://openalex.org/W2030246527","https://openalex.org/W2142262544","https://openalex.org/W2081090975","https://openalex.org/W2410441707","https://openalex.org/W2395981026","https://openalex.org/W2108919161","https://openalex.org/W1999807193","https://openalex.org/W1856715645","https://openalex.org/W2147056569","https://openalex.org/W145667796"],"abstract_inverted_index":{"Twenty":[0],"patients":[1,43,58,63,90,146,187,199],"with":[2,222,231],"severe":[3,209],"plaque":[4],"psoriasis":[5,211,221],"were":[6,179],"selected":[7],"to":[8,68,107,162,212],"receive":[9],"either":[10],"low-dose":[11],"cyclosporin":[12],"A":[13],"(CyA)":[14],"or":[15,105,160,226],"placebo":[16,65],"(CyA":[17],"vehicle)":[18],"in":[19,33,41,56,75,79,109,129,135,183,195,208,220],"a":[20,66,76,84,115,120,149,154,169,227],"double-blind":[21],"randomized":[22],"trial":[23],"at":[24,166],"two":[25],"centres.":[26],"Within":[27],"4":[28,73,112],"weeks":[29,74],"the":[30,34,53,131],"mean":[31,54,77,122,170],"reduction":[32,55,78],"Psoriasis":[35],"Area":[36],"and":[37,189],"Severity":[38],"Index":[39],"(PASI)":[40],"10":[42,57],"receiving":[44,59],"CyA":[45,69,92,123,144,225,230],"(mean":[46,94],"dose":[47,95,124],"5.5":[48],"mg/kg/day)":[49,97,126],"differed":[50],"significantly":[51],"from":[52],"placebo.":[60],"In":[61,83,114],"eight":[62],"given":[64,91],"switch":[67],"therapy":[70],"resulted":[71],"within":[72,111],"PASI":[80,110,133],"of":[81,88,102,137,142,164,172,185,197,218,224,229],"90%.":[82],"total":[85],"15":[86],"out":[87,141],"18":[89,186,198],"(83%)":[93],"5.6":[96],"there":[98],"was":[99,127],"an":[100],"improvement":[101],"greater":[103,158],"than":[104,159],"equal":[106,161],"75%":[108],"weeks.":[113,174],"2-month":[116],"tapering":[117],"off":[118],"phase":[119,152],"lower":[121],"(3":[125],"effective":[128],"maintaining":[130],"reduced":[132],"scores":[134],"seven":[136],"nine":[138],"patients.":[139],"Four":[140],"five":[143],"treated":[145],"who":[147],"entered":[148],"post-treatment":[150],"observation":[151],"had":[153],"relapse":[155],"(PASI":[156],"score":[157,165],"50%":[163],"baseline)":[167],"after":[168],"interval":[171],"6.5":[173],"The":[175],"most":[176],"important":[177],"side-effects":[178],"mild":[180],"reversible":[181,190],"hypertension":[182],"5":[184],"(28%),":[188],"elevated":[191],"serum":[192],"creatinine":[193],"levels":[194],"7":[196],"(39%).":[200],"We":[201],"consider":[202],"that":[203],"further":[204],"studies":[205],"are":[206],"justified":[207],"chronic":[210],"establish":[213],"suitable":[214],"regimens":[215],"for":[216],"maintenance":[217],"remission":[219],"low-doses":[223],"combination":[228],"other":[232],"anti-psoriatic":[233],"agents.":[234]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}